Pharma stock play


PETALING JAYA: Rubber glove makers have taken a step back from their dominance of the stock exchange to pave way for pharmaceutical companies, following a shift in interest among investors.

Two research trials in China and the United Kingdom which yielded positive results drove investors into a frenzy to enter pharmaceutical-related companies, not only on Bursa Malaysia but also in key markets globally.

5.5 PAYDAY OFFER: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Ringgit seen to trade within RM3.96-RM3.98 against US dollar next week
Too close for comfort
The invisible M40
Why international families favour KL
Ringgit strength, IMF’s GDP forecast signal global confidence in Malaysia’s economy, says Muhammad Kamil
Calm markets supercharge carry trade
Secondhand luxury sellers go global
Rethinking China manufacturing
DPS jumps on data centre wave
The art of business

Others Also Read